HFA Premium Access

In HFrEF patients, reduced doses of sacubitril / valsartan do not result in increased mortality or heart failure hospitalizations compared to target dose. A retrospective cohort study

Congress Session

About the speaker

Doctor Renato De Vecchis

Hospital San Gennaro - ASL Napoli 1 Centre, Naples (Italy)
4 presentations
0 follower

38 more presentations in this session

Tertiary heart failure care in the netherlands: what is the added value

Speaker: Miss M. Vester (Leiden, NL)

Thumbnail

The protective effect of beta-blockers in 3,278 advanced heart failure patients treated with continuous inotropes

Speaker: Doctor O. Havakuk (Tel Aviv, IL)

Thumbnail

The benefits of ivabradine in the management of angina pectoris and heart failure.

Speaker: Doctor R. ZAINAB (Tangier, MA)

Thumbnail

Anti diabetic therapy in patients with heart failure and type 2 diabetes mellitus in general population.

Thumbnail

The association between adherence to evidence-based medicines and outcomes in seniors with heart failure: a landmark analysis

Thumbnail

Access the full session

Poster Session 3 - Chronic Heart Failure – Treatment

Speakers: Doctor R. De Vecchis, Miss M. Vester, Doctor O. Havakuk, Doctor R. ZAINAB
Thumbnail

About the event

Image

Heart Failure 2018 & World Congress on Acute Heart Failure

26 May - 29 May 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk